<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30087" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Threatened Miscarriage</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mouri</surname>
            <given-names>MIchelle</given-names>
          </name>
          <aff>DRMC</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hall</surname>
            <given-names>Heather</given-names>
          </name>
          <aff>Garden City Hospital and Michigan State University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rupp</surname>
            <given-names>Timothy J.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>MIchelle Mouri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Heather Hall declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Timothy Rupp declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30087.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>A threatened miscarriage also called a "threatened abortion" or "threatened early pregnancy loss," typically refers to vaginal bleeding and uterine cramping in an otherwise viable pregnancy before 20 weeks of gestation, though more commonly occurring in the first trimester.&#x000a0;In a threatened miscarriage, the cervical os remains closed, and the fetus or embryo remains viable.&#x000a0;Evaluation of threatened miscarriage depends on the pregnancy's gestational age. At early gestational ages, it is essential to establish the location of the pregnancy to rule out an ectopic pregnancy, which can also present with vaginal bleeding and lower abdominal pain. Once an intrauterine pregnancy has been established, the clinician must determine the viability of the pregnancy, which is accomplished through a pelvic examination and ultrasound. If fetal cardiac activity is not seen, serial ultrasound examinations may be required to differentiate an early viable pregnancy from a pregnancy loss. Typically, threatened miscarriages are managed expectantly with close clinical monitoring.&#x000a0;This activity for healthcare professionals is designed to enhance the learner's competence when evaluating, implementing, and educating patients on threatened miscarriage and its management.&#x000a0;By participating in this continuing education activity, clinicians will gain a comprehensive understanding of the risks, benefits, and monitoring parameters involved in managing threatened miscarriage, enabling them to provide evidence-based and patient-centered care.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Define threatened miscarriage and review how to identify it.</p></list-item><list-item><p>Explain the diagnostic evaluation for patients presenting with bleeding in early pregnancy.</p></list-item><list-item><p>Explain the management of a patient presenting with a threatened miscarriage.</p></list-item><list-item><p>Describe how an interprofessional team can optimize outcomes for patients with a threatened miscarriage.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30087&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30087">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30087.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>A pregnancy loss or "miscarriage" generally is defined as pregnancy failure before 20 weeks of gestation.<xref ref-type="bibr" rid="article-30087.r1">[1]</xref> A threatened miscarriage also called a "threatened abortion" or "threatened early pregnancy loss," typically refers to vaginal bleeding and uterine cramping in an otherwise viable pregnancy before 20 weeks of gestation, though more commonly occurring in the first trimester.<xref ref-type="bibr" rid="article-30087.r2">[2]</xref>&#x000a0;A viable pregnancy is a pregnancy with the potential outcome of a live birth.<xref ref-type="bibr" rid="article-30087.r3">[3]</xref>&#x000a0;First-trimester vaginal bleeding and cramping are also common symptoms of early pregnancy loss and incomplete miscarriage. However, characteristic clinical findings of a threatened miscarriage are a closed cervical os, without passage of products of conception, and no evidence of fetal or embryonic demise on pelvic ultrasound.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref></p>
        <p>Approximately 25% of pregnancies have some degree of vaginal bleeding during the first trimester, and approximately half of these patients progress to early pregnancy loss.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref>&#x000a0;The bleeding during a threatened miscarriage is typically mild to moderate; heavier bleeding that is more than typical menstrual flow is associated with an increased risk&#x000a0;of pregnancy loss.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref>&#x000a0;Intermittent cramping, suprapubic pain, pelvic pressure, or lower back pain are also common.<xref ref-type="bibr" rid="article-30087.r5">[5]</xref><xref ref-type="bibr" rid="article-30087.r4">[4]</xref></p>
        <p>Evaluation of threatened miscarriage depends on the pregnancy's gestational age. At early gestational ages, it is important to establish the location of the pregnancy to rule out an ectopic pregnancy, which can also present with vaginal bleeding and lower abdominal pain. Once an intrauterine pregnancy has been established, the clinician must determine the viability of the pregnancy, which is accomplished through a pelvic examination and ultrasound. If fetal cardiac activity is not seen, serial ultrasound examinations may be required to differentiate an early viable pregnancy from a pregnancy loss.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref></p>
        <p>Historically, the term "abortion" has been used to refer to any pregnancy loss before 20 weeks, though&#x000a0;many leading professional organizations&#x000a0;now recommend using variations of the terms "miscarriage" or "pregnancy loss" (eg, threatened miscarriage, threatened pregnancy loss) as patients prefer these terms.<xref ref-type="bibr" rid="article-30087.r2">[2]</xref></p>
      </sec>
      <sec id="article-30087.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact etiology of a threatened miscarriage may not always be determined; however, possible causes include subchorionic hemorrhage or hematoma, eventual spontaneous miscarriage, or nonobstetric bleeding. Bleeding due to subchorionic hemorrhage or hematoma occurs in 18% to 22% of pregnancies, secondary to bleeding between the fetal membranes and the decidua basalis.<xref ref-type="bibr" rid="article-30087.r1">[1]</xref> Though small subchorionic hematomas are not associated with an increased risk of miscarriage, hematomas that measure large than two-thirds of the gestational sac circumference have been found to have an increased risk of progressing to pregnancy loss.<xref ref-type="bibr" rid="article-30087.r6">[6]</xref>&#x000a0;In cases where bleeding is related to an impending early pregnancy loss, fetal chromosomal abnormalities, the most common underlying etiology of all early miscarriages, are present in at least half of affected pregnancies.<xref ref-type="bibr" rid="article-30087.r2">[2]</xref><xref ref-type="bibr" rid="article-30087.r7">[7]</xref><xref ref-type="bibr" rid="article-30087.r8">[8]</xref>&#x000a0;Nonobstetric causes of bleeding in viable intrauterine pregnancies include vaginitis, cervicitis, or cervical polyps.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref></p>
      </sec>
      <sec id="article-30087.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Threatened miscarriage can occur in any pregnancy regardless of maternal age, race, comorbidities, lifestyle, or socioeconomic status.<xref ref-type="bibr" rid="article-30087.r9">[9]</xref>&#x000a0;Approximately 25% of pregnant people have some amount of vaginal bleeding or spotting during the first trimester; in pregnancies with detectable fetal cardiac activity, 11% ultimately miscarry.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref></p>
      </sec>
      <sec id="article-30087.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of threatened miscarriage depends on the underlying etiology of the symptoms. Subchorionic hemorrhage is caused by bleeding between the decidua basalis and the gestational sac.<xref ref-type="bibr" rid="article-30087.r1">[1]</xref>&#x000a0; Conditions causing nonobstetric bleeding and cramping (eg, cervicitis or cervical trauma) include infectious processes leading to vascular permeability and cytokine-mediated inflammation of cervical and vaginal mucosa and trauma-related injury to the maternal abdomen or pelvic organs.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref><xref ref-type="bibr" rid="article-30087.r10">[10]</xref><xref ref-type="bibr" rid="article-30087.r11">[11]</xref></p>
      </sec>
      <sec id="article-30087.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>History</bold>
</p>
        <p>Patients with a threatened miscarriage typically present with bleeding and cramping in the first trimester, though&#x000a0;some patients may be unaware of their pregnancy and complain of irregular menstrual bleeding.<xref ref-type="bibr" rid="article-30087.r12">[12]</xref>&#x000a0; These symptoms may occur during normal and abnormal gestations (eg, ectopic and molar pregnancies); therefore, a comprehensive evaluation must be conducted to exclude more concerning pregnancy complications.<xref ref-type="bibr" rid="article-30087.r2">[2]</xref> A thorough medical history should be obtained, including an obstetrical and menstrual history. Clinicians can calculate an estimated due date using the first day of the last menstrual period; though, a first-trimester&#x000a0;obstetrical ultrasound is&#x000a0;considered more accurate and should be used to determine the gestational age if available.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref>&#x000a0; Previous ultrasounds can also help confirm that the pregnancy is located within the uterus.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref><xref ref-type="bibr" rid="article-30087.r12">[12]</xref></p>
        <p>In a threatened miscarriage, the volume of bleeding can range from light spotting to bleeding heavier than a typical menstrual period; in general, the heavier the bleeding, the more concerning it is that the pregnancy will result in a miscarriage.<xref ref-type="bibr" rid="article-30087.r13">[13]</xref><xref ref-type="bibr" rid="article-30087.r14">[14]</xref>&#x000a0;Patients with threatened miscarriages are almost always hemodynamically stable; even patients expectantly managed that proceed to have spontaneous pregnancy loss only require a blood transfusion 1% of the time.<xref ref-type="bibr" rid="article-30087.r15">[15]</xref>&#x000a0;The clinician should estimate the amount of bleeding a patient is experiencing by asking when the bleeding began, how often she is soaking or changing menstrual hygiene products, if she is passing any clots or tissue, and if she has any associated symptoms, such as dizziness or lightheadedness.<xref ref-type="bibr" rid="article-30087.r12">[12]</xref> The provider should also ask about precipitating factors; if the bleeding started after cervical contact (eg, after intercourse or a pelvic exam), this might indicate cervical or vaginal, rather than uterine, pathology.<xref ref-type="bibr" rid="article-30087.r12">[12]</xref></p>
        <p>Additionally, the provider should elicit the characteristics of any associated pain or cramping, the severity of which can vary widely.<xref ref-type="bibr" rid="article-30087.r12">[12]</xref> On one end of the spectrum, bleeding may be completely painless, while for other patients, the bleeding&#x000a0;may be accompanied by intensely painful menstrual-like cramping that radiates to the back and upper thighs. Like with bleeding, severe pain is more concerning for impending pregnancy loss.<xref ref-type="bibr" rid="article-30087.r14">[14]</xref></p>
        <p>
<bold>Physical Exam Findings</bold>
</p>
        <p>Key components of the physical examination should include an assessment of the patient's hemodynamic stability, including a review of the vital signs and a focused abdominal and pelvic examination.<xref ref-type="bibr" rid="article-30087.r12">[12]</xref>&#x000a0;Patients with only a threatened miscarriage will be hemodynamically stable and have normal cardiovascular and respiratory findings; hemodynamic instability indicates heavier bleeding that is more commonly seen with miscarriages in progress (eg, incomplete miscarriage).<xref ref-type="bibr" rid="article-30087.r2">[2]</xref> The abdominal exam is also typically benign (eg, non-tender, non-distended, and soft), though patients may have mild tenderness to palpation in the lower pelvis over the uterus. Peritoneal signs, such as guarding, rebound tenderness, or abdominal rigidity, are not typically present in an uncomplicated threatened miscarriage; if found, they&#x000a0;indicate the need for an emergent obstetrical or general surgery consultation.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref></p>
        <p>A pelvic exam is mandatory whenever a pregnant patient presents with bleeding to assess the amount and site of bleeding, cervical dilation, possible nonobstetric sources of bleeding, and whether fetal tissue is present in the cervix or vagina.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref> During the pelvic exam, suction, cotton swabs, or ring forceps may be needed to remove&#x000a0;blood in the vagina or cervix to allow for better visualization; the clinician should assess any vaginal discharge and collect specimens as needed for testing.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref><xref ref-type="bibr" rid="article-30087.r16">[16]</xref> &#x000a0;</p>
        <p>In a threatened miscarriage, the typical findings during vaginal examination are a closed cervical os with no fetal or embryonic tissue in the vaginal vault, though blood may be noted.<xref ref-type="bibr" rid="article-30087.r1">[1]</xref> There is usually no cervical motion tenderness, though depending on the severity of cramping, patients may note some uterine or adnexal discomfort.<xref ref-type="bibr" rid="article-30087.r16">[16]</xref>&#x000a0;Significant tenderness of the pelvic organs, especially if purulent vaginal discharge is present,&#x000a0;suggests the presence of an infection.<xref ref-type="bibr" rid="article-30087.r16">[16]</xref></p>
        <p>The pelvic exam is also essential to rule out alternative causes of vaginal bleeding in pregnancy, including vulvar, vaginal, and cervical lacerations, erosions, dysplasia or neoplasms, polyps, fibroids, or friability in the setting of an infection (eg, vaginal candidiasis,&#x000a0;<italic toggle="yes">Chlamydia trachomatis</italic> infection, condyloma acuminata). Additionally, an adnexal mass may suggest an ectopic pregnancy or other gynecologic pathologies, such as a cyst or ovarian torsion.<xref ref-type="bibr" rid="article-30087.r14">[14]</xref></p>
      </sec>
      <sec id="article-30087.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Components of the Evaluation</bold>
</p>
        <p>In addition to a history and physical exam, components of the diagnostic evaluation of a threatened miscarriage include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pelvic ultrasound</p>
          </list-item>
          <list-item>
            <p>Serum quantitative beta-human chorionic gonadotropin (&#x003b2;-hCG)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Blood type and Rh status</p>
          </list-item>
          <list-item>
            <p>Hemoglobin and hematocrit</p>
          </list-item>
          <list-item>
            <p>Additional labs for concerns of infection (eg, cultures of endocervical secretions, blood, and urine; complete blood count with a differential; comprehensive metabolic panel; and serum lactate)<xref ref-type="bibr" rid="article-30087.r4">[4]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Pelvic Ultrasound</bold>
</p>
        <p>Transvaginal ultrasound is preferred over other modalities for the evaluation of first-trimester pregnancies.<xref ref-type="bibr" rid="article-30087.r6">[6]</xref>&#x000a0;In correlation with &#x003b2;-hCG levels, it is used to locate the pregnancy, determine the viability and gestational age of the pregnancy, and assess the pelvis for other contributing complications.<xref ref-type="bibr" rid="article-30087.r1">[1]</xref>&#x000a0;</p>
        <p><bold>Assessing location:</bold>&#x000a0;Threatened miscarriage is considered a diagnosis of exclusion; the most important diagnosis to rule out when evaluating bleeding in early pregnancy is an ectopic pregnancy, which commonly presents with bleeding and abdominal pain.<xref ref-type="bibr" rid="article-30087.r17">[17]</xref>&#x000a0;In a threatened miscarriage, an intrauterine pregnancy will be identified, or if neither an early intrauterine nor ectopic pregnancy is visualized, a pregnancy of unknown location (PUL) may be diagnosed. Embryonic or fetal structures (eg, a yolk sac or fetus)&#x000a0;must be seen within the endometrial cavity to confirm an intrauterine pregnancy. A PUL is considered a temporary diagnosis that eventually must be determined to be an ectopic pregnancy, a miscarriage, or a very early intrauterine pregnancy through serial ultrasounds and&#x000a0;&#x003b2;-hCG levels.<xref ref-type="bibr" rid="article-30087.r18">[18]</xref>&#x000a0;&#x000a0;</p>
        <p><bold>Assessing viability:&#x000a0;</bold>The pregnancy is considered viable if fetal cardiac activity (FCA) is present. At earlier gestational ages before the development of FCA, intrauterine pregnancy failure may be identified based on a set of ultrasound criteria from a 2012 multispecialty panel from the Society of Radiologists in Ultrasound.<xref ref-type="bibr" rid="article-30087.r18">[18]</xref><xref ref-type="bibr" rid="article-30087.r2">[2]</xref><xref ref-type="bibr" rid="article-30087.r18">[18]</xref>&#x000a0;According to these criteria, pregnancy failure may be highly likely if one of the following is present:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>A fetal crown-rump length (CRL) of &#x02265;7 mm without FCA</p>
          </list-item>
          <list-item>
            <p>A mean sac diameter (MSD) of &#x02265;25 mm without an embryo</p>
          </list-item>
          <list-item>
            <p>Absence of an embryo with FCA &#x02265;14 days after a scan showing a gestational sac (GS) without a yolk sac (YS)</p>
          </list-item>
          <list-item>
            <p>Absence of an embryo with FCA &#x02265;11 days after a scan showing a GS with a YS</p>
          </list-item>
        </list>
        <p><bold>Assessing the pelvis for nonobstetric causes of presentation:&#x000a0;</bold>Ultrasound is the imaging modality of choice to evaluate the internal pelvic organs. In addition to looking for evidence of an ectopic pregnancy, ultrasound can assist in assessing other alternative diagnoses, including ruptured or torsed adnexal masses, gestational trophoblastic disease, and appendicitis.<xref ref-type="bibr" rid="article-30087.r14">[14]</xref>&#x000a0;Additional imaging, such as an abdominal radiograph or CT scan, can also be considered, depending on the severity of the presentation and clinical suspicion.<xref ref-type="bibr" rid="article-30087.r19">[19]</xref></p>
        <p>
<bold>Laboratory Evaluation</bold>
</p>
        <p><bold>Quantitative &#x003b2;-hCG&#x000a0;level:</bold> Early in gestation, the serum &#x003b2;-hCG increases at a relatively predictable rate in viable intrauterine pregnancies (IUPs); this increase may be abnormally slow in ectopic pregnancy or decrease in failing pregnancies.&#x000a0;Therefore, serial &#x003b2;-hCG levels can help identify abnormal early pregnancies. For patients with a PUL, the trend in serial &#x003b2;-hCG levels, interpreted in conjunction with serial pelvic ultrasound examinations, is used to make the final diagnosis.<xref ref-type="bibr" rid="article-30087.r2">[2]</xref><xref ref-type="bibr" rid="article-30087.r18">[18]</xref>&#x000a0;Once FCA is visible, however, normal &#x003b2;-hCG values can vary widely, with the rate of increase slowing over time, ultimately plateauing by about 10 weeks of gestation. For this reason, once&#x000a0;FCA has been detected in an IUP, an &#x003b2;-hCG level is generally not indicated, and transvaginal ultrasound should primarily be used for diagnosis.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref>&#x000a0;&#x000a0;In patients who already have evidence of an&#x000a0;IUP but do not yet demonstrate a fetus with FCA (eg, a transvaginal ultrasound demonstrating only an intrauterine GS with a YS), an &#x003b2;-hCG level can be appropriate, as falling levels may identify&#x000a0;a miscarriage sooner than if the clinician is relying on ultrasound alone; in these situations, however, a repeat &#x003b2;-hCG level is not strictly required since ectopic pregnancy has already been ruled out based on the ultrasound findings.<xref ref-type="bibr" rid="article-30087.r20">[20]</xref><xref ref-type="bibr" rid="article-30087.r21">[21]</xref><xref ref-type="bibr" rid="article-30087.r22">[22]</xref></p>
        <p><bold>Blood count:</bold>&#x000a0;Assessment of the hemoglobin and hematocrit, typically with a complete blood count, is usually recommended except in cases where bleeding is scant (eg, an episode of spotting) and a baseline blood count was recently done (eg, at a recent initial prenatal visit). However, assessing the degree of blood loss is appropriate for most patients.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref><xref ref-type="bibr" rid="article-30087.r23">[23]</xref></p>
        <p><bold>Blood type and&#x000a0;Rh&#x000a0;status:</bold> In&#x000a0;patients with significant vaginal bleeding, blood type and Rh status should be confirmed in anticipation of possible blood transfusion, surgical blood loss, or Rh(D)-alloimmunization prophylaxis.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref>&#x000a0;If the pregnant person is Rh(D)-negative, they may develop antibodies against the Rh(D) antigen if they are exposed to Rh(D)-positive fetal blood. This is known as alloimmunization and can lead to future hemolytic disease of the newborn.<xref ref-type="bibr" rid="article-30087.r24">[24]</xref>&#x000a0;Knowledge of a patient's Rh status becomes more important as the pregnancy progresses due to the risk of&#x000a0;Rh(D)-alloimmunization increasing as the number of fetal erythrocytes increases.<xref ref-type="bibr" rid="article-30087.r2">[2]</xref>&#x000a0;Approximately 11% of patients with a threatened miscarriage may experience maternal exposure to fetal blood and thus be at risk for alloimmunization.<xref ref-type="bibr" rid="article-30087.r25">[25]</xref> Patients at risk of alloimmunization (eg, an Rh-negative pregnant person with bleeding) can be given Rh(D)-immune globulin to prevent the development of these antibodies; however, international guidelines vary regarding its use in the first trimester.<xref ref-type="bibr" rid="article-30087.r24">[24]</xref></p>
        <p><bold>Additional labs:</bold> A urinalysis is typically obtained as a urinary tract infection (UTI) may present with similar signs and symptoms.&#x000a0;If there is a concern for a pelvic infection based on the patient's history and exam, additional testing is recommended, including blood and urine cultures,&#x000a0; sexually transmitted infection cultures, serum lactate, and a comprehensive metabolic panel.<xref ref-type="bibr" rid="article-30087.r19">[19]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-30087.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Expectant Management</bold>
</p>
        <p>Patients with viable intrauterine pregnancies diagnosed with a threatened miscarriage should be expectantly managed after the exclusion of differential diagnoses. A pelvic ultrasound should be repeated if any further bleeding occurs. In patients in which the pregnancy's viability or location is uncertain, pelvic ultrasound should be repeated and serial&#x000a0;&#x003b2;-hCG levels performed. For PULs in patients who remain hemodynamically stable,&#x000a0;an&#x000a0;&#x003b2;-hCG level should be obtained every 48 hours until the location of the pregnancy or pregnancy failure is identified.<xref ref-type="bibr" rid="article-30087.r2">[2]</xref></p>
        <p>Progesterone supplementation has been investigated as a possible therapy to reduce the risk of pregnancy loss in patients at high risk for miscarriage, including those with a threatened miscarriage or a shortened cervix.<xref ref-type="bibr" rid="article-30087.r26">[26]</xref><xref ref-type="bibr" rid="article-30087.r27">[27]</xref>&#x000a0;For people <italic toggle="yes">without</italic> a history of miscarriage, vaginal progesterone likely has little to no benefit. It is generally&#x000a0;<italic toggle="yes">not</italic> recommended unless they are found to have a cervical length of 25 mm or less.<xref ref-type="bibr" rid="article-30087.r27">[27]</xref><xref ref-type="bibr" rid="article-30087.r28">[28]</xref><xref ref-type="bibr" rid="article-30087.r27">[27]</xref><xref ref-type="bibr" rid="article-30087.r29">[29]</xref>&#x000a0;Evidence from the recent PRISM and PROMISE trials suggests that for people <italic toggle="yes">with</italic> a history of prior early pregnancy loss, vaginal&#x000a0;progesterone does appear to be beneficial. Study authors recommended vaginal micronized progesterone 400 mg twice daily, initiated when a patient presents with symptoms of vaginal bleeding, continuing until 16 weeks of gestation.<xref ref-type="bibr" rid="article-30087.r26">[26]</xref>&#x000a0;</p>
        <p>
<bold>Prevent Alloimmunization</bold>
</p>
        <p>Alloimmunization can be prevented by administering Rh(D)-immune globulin; however, guidelines vary, and its use in the first trimester is somewhat controversial due to the low risk of alloimmunization in the first trimester.<xref ref-type="bibr" rid="article-30087.r24">[24]</xref>&#x000a0;The Rh(D)-antigen is found on fetal erythrocytes, so alloimmunization is theoretically improbable before the development of&#x000a0;these cells.&#x000a0;The&#x000a0;Rh(D)-antigen has been identified as early as&#x000a0;7 3/7 weeks of gestation.<xref ref-type="bibr" rid="article-30087.r24">[24]</xref>&#x000a0;Additionally, only&#x000a0;3% to 11% of pregnant people may be exposed to fetal blood during a threatened miscarriage, with the risk of alloimmunization increasing with heavier bleeding, older gestational age, and surgical procedures, such as chorionic villus sampling.</p>
        <p>Given a lack of clear evidence to guide decision-making, the American College of Obstetricians and Gynecologists (ACOG) recommends that Rh(D)-immune globulin be considered for all Rh(D)-negative patients who have vaginal bleeding in early pregnancy, "especially those that are later in the first trimester."<xref ref-type="bibr" rid="article-30087.r24">[24]</xref><xref ref-type="bibr" rid="article-30087.r30">[30]</xref>&#x000a0;Conversely, the National Institutes of Health and Care Excellence (NICE) guidelines from the UK explicitly recommend <italic toggle="yes">against</italic> its use before 12 weeks of gestation, while guidelines from the British Committee for Standards in Haematology (BCSH) that are supported by the Royal College of Obstetricians and Gynaecologists (RCOG) do consider it appropriate to give before 12 weeks when uterine bleeding is "repeated, heavy, or associated with abdominal pain."<xref ref-type="bibr" rid="article-30087.r31">[31]</xref></p>
        <p>If given in the first trimester, a dose of Rh(D)-immune globulin 50-120 mcg IM once is effective at alloimmunization prevention; after 12 weeks of gestation,&#x000a0;Rh(D)-immune globulin 300 mcg IM once is typically preferred in the US, though other guidelines recommend lower doses depending on the situation.<xref ref-type="bibr" rid="article-30087.r32">[32]</xref>&#x000a0;</p>
        <p>
<bold>Discharge Instructions and Appropriate Follow-up</bold>
</p>
        <p>The importance of follow-up should be emphasized, and patients should be&#x000a0;instructed to return for evaluation earlier than scheduled if they experience&#x000a0;excessive vaginal bleeding, typically defined as soaking at least 1 to 2 pads for at least 2 hours in a row, worsening abdominal pain, or fever. Patients should also be reassured that they are not at fault for causing symptoms.<xref ref-type="bibr" rid="article-30087.r2">[2]</xref></p>
        <p>There is no evidence that bed rest prevents early pregnancy loss and should not be recommended.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref><xref ref-type="bibr" rid="article-30087.r33">[33]</xref><xref ref-type="bibr" rid="article-30087.r34">[34]</xref>&#x000a0; Some clinicians prefer to advise patients to avoid strenuous activities and maintain pelvic rest (ie, avoiding vaginal intercourse) at least until the cessation of vaginal bleeding. However, this recommendation is not based on evidence. Clinicians should recommend that patients start or continue to take prenatal vitamins with folic acid supplementation.<xref ref-type="bibr" rid="article-30087.r35">[35]</xref><xref ref-type="bibr" rid="article-30087.r36">[36]</xref><xref ref-type="bibr" rid="article-30087.r37">[37]</xref><xref ref-type="bibr" rid="article-30087.r38">[38]</xref></p>
      </sec>
      <sec id="article-30087.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Clinicians should consider several differential diagnoses when a pregnant person presents with vaginal bleeding and pelvic pain, as threatened miscarriage is ultimately a diagnosis of exclusion.<xref ref-type="bibr" rid="article-30087.r14">[14]</xref><xref ref-type="bibr" rid="article-30087.r39">[39]</xref> The differential diagnosis includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Obstetric diagnoses
<list list-type="bullet"><list-item><p>Ectopic pregnancy</p></list-item><list-item><p>Early pregnancy loss (eg, inevitable, incomplete, complete, or septic miscarriage)</p></list-item><list-item><p>Gestational trophoblastic disease</p></list-item><list-item><p>Cervical incompetence, typically in the second trimester</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Vulvar, vaginal, and cervical diagnoses (eg, trauma, vaginal candidiasis, bacterial vaginosis, <italic toggle="yes">Chlamydia</italic>&#x000a0;<italic toggle="yes">trachomatis</italic> infection, condyloma acuminata, cervical polyps, cervical malignancy)</p>
          </list-item>
          <list-item>
            <p>Adnexal diagnoses (eg, ruptured corpus luteal cyst, adnexal torsion)</p>
          </list-item>
          <list-item>
            <p>Other diagnoses (eg, appendicitis, urinary tract infection, inflammatory bowel disease)&#x000a0;</p>
          </list-item>
        </list>
        <p>Ultrasound and &#x003b2;-hCG assessments can rule out ectopic pregnancy and early pregnancy loss. Differentiation of threatened miscarriage from other early pregnancy loss is primarily based on pelvic ultrasound and physical examination findings. In a threatened&#x000a0;miscarriage,&#x000a0;the cervical os is closed, and an ultrasound demonstrates evidence of a viable pregnancy.<xref ref-type="bibr" rid="article-30087.r40">[40]</xref>&#x000a0;These observations differentiate a threatened miscarriage from other types of miscarriage. For example, with an inevitable miscarriage, the cervical os is open without visualization of POC in the vaginal vault. In contrast, an open cervix with partial passage of POC characterizes an incomplete miscarriage. A nonviable pregnancy excludes the diagnosis of threatened miscarriage.<xref ref-type="bibr" rid="article-30087.r1">[1]</xref>&#x000a0;Ultrasound and history can also help rule out other adnexal and nonobstetric causes, such as appendicitis. Physical examinations and clinically appropriate testing can typically rule out vulvar, vaginal, and cervical causes.</p>
      </sec>
      <sec id="article-30087.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Bleeding and cramping in early pregnancy are extremely common. Studies have shown that about 25% of pregnant people experience vaginal bleeding before 20 weeks of gestation, and between 12% to 57% of these patients will ultimately progress to early pregnancy loss. Heavy bleeding, especially when accompanied by pain or cramping, carries a significantly worse prognosis than light bleeding or spotting.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref><xref ref-type="bibr" rid="article-30087.r23">[23]</xref></p>
        <p>Pregnancies complicated by threatened miscarriage also have an increased risk of adverse outcomes later in pregnancy, including pregnancy loss, preterm birth, preterm premature rupture of membranes, intrauterine fetal growth restriction, and placental abruption. Furthermore, patients who proceed to experience early pregnancy loss have an increased risk of&#x000a0;depression, sleep disturbance, anger, and marital disturbances.<xref ref-type="bibr" rid="article-30087.r27">[27]</xref></p>
      </sec>
      <sec id="article-30087.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of threatened miscarriage include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Early pregnancy loss&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Anemia</p>
          </list-item>
          <list-item>
            <p>Poor mental health (eg, depression, anxiety)</p>
          </list-item>
          <list-item>
            <p>Adverse outcomes later in pregnancy (eg, preterm labor, placental abruption)&#x000a0;<xref ref-type="bibr" rid="article-30087.r27">[27]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30087.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>An obstetrical clinician should be consulted for patients with bleeding during pregnancy. For most stable patients who present to an emergency department, outpatient referral to an obstetrical specialist for close follow-up and prenatal care is appropriate. However, an obstetrician should be consulted immediately in patients with hemodynamic instability or in cases of diagnostic uncertainty.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref>&#x000a0;</p>
        <p>Persistent bleeding in pregnancy may also warrant referral to a maternal-fetal medicine (MFM) specialist.&#x000a0;Patients with recurrent pregnancy loss can be referred to a&#x000a0;reproductive endocrinology and infertility (REI) specialist.<xref ref-type="bibr" rid="article-30087.r9">[9]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-30087.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education should be provided in both written and verbal forms. The patient should be informed if the pregnancy is viable and that continuation of the pregnancy commonly occurs, especially if the bleeding is light and there is no accompanying discomfort. She should be counseled on the risk of progression to miscarriage and that there may be no proven prevention strategies in many cases. Patients may feel extreme guilt or anxiety during a threatened miscarriage, and it is essential to reassure the patient that she is not at fault should a miscarriage occur.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref>&#x000a0;</p>
        <p>Providers should explain what to expect during expectant management, including normal symptoms (eg, mild to moderate bleeding and cramping); for any uncontrolled pain, fever, or heavy bleeding defined as soaking 1 to 2 pads per hour for &#x02265;2 hours, they should be evaluated promptly by an obstetric care provider or in the emergency department.<xref ref-type="bibr" rid="article-30087.r41">[41]</xref><xref ref-type="bibr" rid="article-30087.r4">[4]</xref></p>
        <p>Patients can be offered acetaminophen or paracetamol for pain relief but should generally be instructed to avoid NSAIDs while the pregnancy is still viable.&#x000a0;Bedrest and activity restriction should not be recommended, though many providers recommend pelvic rest until symptoms resolve despite a lack of evidence supporting this recommendation.<xref ref-type="bibr" rid="article-30087.r4">[4]</xref><xref ref-type="bibr" rid="article-30087.r2">[2]</xref></p>
      </sec>
      <sec id="article-30087.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>A threatened miscarriage is a diagnosis of exclusion that should be made in pregnant patients determined to have viable pregnancies with symptoms of vaginal bleeding.</p>
          </list-item>
          <list-item>
            <p>Subchorionic hematomas are associated with threatened miscarriage; pregnancies with large subchorionic hematomas have a higher risk of early pregnancy loss.</p>
          </list-item>
          <list-item>
            <p>The initial steps when evaluating bleeding in early pregnancy are to determine the location of the pregnancy and then assess viability using ultrasound.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Patients with heavy vaginal bleeding require evaluation for hemorrhagic anemia; it often indicates impending early pregnancy loss.</p>
          </list-item>
          <list-item>
            <p>Patients with a threatened miscarriage can be managed as an outpatient&#x000a0;with close follow-up and serial ultrasound monitoring as indicated.<xref ref-type="bibr" rid="article-30087.r1">[1]</xref><xref ref-type="bibr" rid="article-30087.r4">[4]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30087.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Diagnosing and managing a threatened miscarriage involves an interprofessional team, including emergency care clinicians, obstetric clinicians, radiology team members, midlevel practitioners, and nursing staff. Coordinating appropriate follow-up for these patients is critical and often involves cooperation between staff members in different departments or practices. Excellent documentation in the medical record, including all lab and radiology reports, is essential to ensure a patient receives optimal care at their follow-up appointment. Furthermore, nonclinical and clinical staff should be trained in communicating sensitively with patients experiencing early pregnancy complications.</p>
      </sec>
      <sec id="article-30087.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30087&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30087">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/threatened-miscarriage/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30087">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30087/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30087">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30087.s17">
        <title>References</title>
        <ref id="article-30087.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murugan</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Dupuis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YH</given-names>
              </name>
            </person-group>
            <article-title>Role of ultrasound in the evaluation of first-trimester pregnancies in the acute setting.</article-title>
            <source>Ultrasonography</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>178</fpage>
            <page-range>178-189</page-range>
            <pub-id pub-id-type="pmid">32036643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <collab>American College of Obstetricians and Gynecologists' Committee on Practice Bulletins&#x02014;Gynecology</collab>
            <article-title>ACOG Practice Bulletin No. 200: Early Pregnancy Loss.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>132</volume>
            <issue>5</issue>
            <fpage>e197</fpage>
            <page-range>e197-e207</page-range>
            <pub-id pub-id-type="pmid">30157093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>American College of&#x000a0;Obstetricians and Gynecologists and the Society for Maternal&#x02013;Fetal Medicine</collab>
              <name>
                <surname>Ecker</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Kaimal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Blackwell</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>deRegnier</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Farrell</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Grobman</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Resnik</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Sciscione</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>#3: Periviable birth.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>213</volume>
            <issue>5</issue>
            <fpage>604</fpage>
            <page-range>604-14</page-range>
            <pub-id pub-id-type="pmid">26506448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hendriks</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>MacNaughton</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>MacKenzie</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>First Trimester Bleeding: Evaluation and Management.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Feb</month>
            <day>01</day>
            <volume>99</volume>
            <issue>3</issue>
            <fpage>166</fpage>
            <page-range>166-174</page-range>
            <pub-id pub-id-type="pmid">30702252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karata&#x0015f;l&#x00131;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kanmaz</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>&#x00130;nan</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Budak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beyan</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Maternal and neonatal outcomes of adolescent pregnancy.</article-title>
            <source>J Gynecol Obstet Hum Reprod</source>
            <year>2019</year>
            <month>May</month>
            <volume>48</volume>
            <issue>5</issue>
            <fpage>347</fpage>
            <page-range>347-350</page-range>
            <pub-id pub-id-type="pmid">30794955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Expert Panel on Women&#x02019;s Imaging:</collab>
              <name>
                <surname>Brown</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Packard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maturen</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Deshmukh</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Dudiak</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Henrichsen</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Poder</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sadowski</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Shipp</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Zelop</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Glanc</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>ACR Appropriateness Criteria<sup>&#x000ae;</sup> First Trimester Vaginal Bleeding.</article-title>
            <source>J Am Coll Radiol</source>
            <year>2018</year>
            <month>May</month>
            <volume>15</volume>
            <issue>5S</issue>
            <fpage>S69</fpage>
            <page-range>S69-S77</page-range>
            <pub-id pub-id-type="pmid">29724428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <collab>Practice Committee of the American Society for Reproductive Medicine</collab>
            <article-title>Evaluation and treatment of recurrent pregnancy loss: a committee opinion.</article-title>
            <source>Fertil Steril</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>98</volume>
            <issue>5</issue>
            <fpage>1103</fpage>
            <page-range>1103-11</page-range>
            <pub-id pub-id-type="pmid">22835448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A cross-sectional survey of pregnant women's knowledge of chromosomal aneuploidy and microdeletion and microduplication syndromes.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>256</volume>
            <fpage>82</fpage>
            <page-range>82-90</page-range>
            <pub-id pub-id-type="pmid">33176246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devall</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Coomarasamy</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sporadic pregnancy loss and recurrent miscarriage.</article-title>
            <source>Best Pract Res Clin Obstet Gynaecol</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>69</volume>
            <fpage>30</fpage>
            <page-range>30-39</page-range>
            <pub-id pub-id-type="pmid">32978069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tantengco</surname>
                <given-names>OAG</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Breaking Down the Barrier: The Role of Cervical Infection and Inflammation in Preterm Birth.</article-title>
            <source>Front Glob Womens Health</source>
            <year>2021</year>
            <volume>2</volume>
            <fpage>777643</fpage>
            <pub-id pub-id-type="pmid">35118439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maslovitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Farine</surname>
                <given-names>D</given-names>
              </name>
              <collab>Maternal Fetal Medicine Committee</collab>
              <name>
                <surname>Bujold</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gagnon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Basso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bos</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gouin</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Menticoglou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mundle</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pylypjuk</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Roggensack</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sanderson</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Guidelines for the Management of a Pregnant Trauma Patient.</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>553</fpage>
            <page-range>553-74</page-range>
            <pub-id pub-id-type="pmid">26334607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pontius</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vieth</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Complications in Early Pregnancy.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2019</year>
            <month>May</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>219</fpage>
            <page-range>219-237</page-range>
            <pub-id pub-id-type="pmid">30940368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chamberlain</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>ABC of antenatal care, Vaginal bleeding in early pregnancy--I.</article-title>
            <source>BMJ</source>
            <year>1991</year>
            <month>May</month>
            <day>11</day>
            <volume>302</volume>
            <issue>6785</issue>
            <fpage>1141</fpage>
            <page-range>1141-3</page-range>
            <pub-id pub-id-type="pmid">2043788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jurkovic</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound imaging in the management of bleeding and pain in early pregnancy.</article-title>
            <source>Best Pract Res Clin Obstet Gynaecol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>621</fpage>
            <page-range>621-36</page-range>
            <pub-id pub-id-type="pmid">24841987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nanda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Grimes</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Peloggia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nanda</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Expectant care versus surgical treatment for miscarriage.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2012</year>
            <month>Mar</month>
            <day>14</day>
            <volume>2012</volume>
            <issue>3</issue>
            <fpage>CD003518</fpage>
            <pub-id pub-id-type="pmid">22419288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Curry</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Penny</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Sep</month>
            <day>15</day>
            <volume>100</volume>
            <issue>6</issue>
            <fpage>357</fpage>
            <page-range>357-364</page-range>
            <pub-id pub-id-type="pmid">31524362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <collab>American College of Obstetricians and Gynecologists' Committee on Practice Bulletins&#x02014;Gynecology</collab>
            <article-title>ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>131</volume>
            <issue>3</issue>
            <fpage>e91</fpage>
            <page-range>e91-e103</page-range>
            <pub-id pub-id-type="pmid">29470343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doubilet</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Blaivas</surname>
                <given-names>M</given-names>
              </name>
              <collab>Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy</collab>
              <name>
                <surname>Barnhart</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Benacerraf</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Filly</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Kendall</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Pretorius</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Timor-Tritsch</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic criteria for nonviable pregnancy early in the first trimester.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>Oct</month>
            <day>10</day>
            <volume>369</volume>
            <issue>15</issue>
            <fpage>1443</fpage>
            <page-range>1443-51</page-range>
            <pub-id pub-id-type="pmid">24106937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eschenbach</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Treating spontaneous and induced septic abortions.</article-title>
            <source>Obstet Gynecol</source>
            <year>2015</year>
            <month>May</month>
            <volume>125</volume>
            <issue>5</issue>
            <fpage>1042</fpage>
            <page-range>1042-1048</page-range>
            <pub-id pub-id-type="pmid">25932831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r20">
          <label>20</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Alves</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jenkins</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Rapp</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Early Pregnancy Loss (Spontaneous Abortion)</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>10</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">32809356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r21">
          <label>21</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Dugas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Slane</surname>
                <given-names>VH</given-names>
              </name>
            </person-group>
            <chapter-title>Miscarriage (Archived)</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>6</month>
            <day>27</day>
            <pub-id pub-id-type="pmid">30422585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r22">
          <label>22</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mummert</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gnugnoli</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <chapter-title>Ectopic Pregnancy</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">30969682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prine</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>MacNaughton</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Office management of early pregnancy loss.</article-title>
            <source>Am Fam Physician</source>
            <year>2011</year>
            <month>Jul</month>
            <day>01</day>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-82</page-range>
            <pub-id pub-id-type="pmid">21766758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <article-title>Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>e57</fpage>
            <page-range>e57-e70</page-range>
            <pub-id pub-id-type="pmid">28742673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Von Stein</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Munsick</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Stiver</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ryder</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Fetomaternal hemorrhage in threatened abortion.</article-title>
            <source>Obstet Gynecol</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>383</fpage>
            <page-range>383-6</page-range>
            <pub-id pub-id-type="pmid">1738519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coomarasamy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Devall</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Brosens</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Quenby</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stephenson</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Sierra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Christiansen</surname>
                <given-names>OB</given-names>
              </name>
              <name>
                <surname>Small</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brewin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Dhillon-Smith</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Harb</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Noordali</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Papadopoulou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eapen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Prior</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Renzo</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Hinshaw</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mol</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Lumsden</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Khalaf</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shennan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goddijn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Wely</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Al-Memar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Regan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gallos</surname>
                <given-names>ID</given-names>
              </name>
            </person-group>
            <article-title>Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>223</volume>
            <issue>2</issue>
            <fpage>167</fpage>
            <page-range>167-176</page-range>
            <pub-id pub-id-type="pmid">32008730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wahabi</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Fayed</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Esmaeil</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Bahkali</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Progestogen for treating threatened miscarriage.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2018</year>
            <month>Aug</month>
            <day>06</day>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>CD005943</fpage>
            <pub-id pub-id-type="pmid">30081430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <article-title>Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234.</article-title>
            <source>Obstet Gynecol</source>
            <year>2021</year>
            <month>Aug</month>
            <day>01</day>
            <volume>138</volume>
            <issue>2</issue>
            <fpage>e65</fpage>
            <page-range>e65-e90</page-range>
            <pub-id pub-id-type="pmid">34293771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Majid</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Niamat Ali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taing</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>El-Serehy</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Al-Misned</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of etiology and pregnancy outcome in recurrent miscarriage patients.</article-title>
            <source>Saudi J Biol Sci</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>2809</fpage>
            <page-range>2809-2817</page-range>
            <pub-id pub-id-type="pmid">32994741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayekar</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Paradkar</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Bhosale</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Sachan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Beeram</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anand</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Mundle</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Trivedi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Md</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patole</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Sambarey</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Daftary</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Divekar</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Recombinant anti-D for prevention of maternal-foetal Rh(D) alloimmunization: a randomized multi-centre clinical trial.</article-title>
            <source>Obstet Gynecol Sci</source>
            <year>2020</year>
            <month>May</month>
            <volume>63</volume>
            <issue>3</issue>
            <fpage>315</fpage>
            <page-range>315-322</page-range>
            <pub-id pub-id-type="pmid">32489976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qureshi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Massey</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kirwan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Robson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Allard</surname>
                <given-names>S</given-names>
              </name>
              <collab>British Society for Haematology</collab>
            </person-group>
            <article-title>BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn.</article-title>
            <source>Transfus Med</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-20</page-range>
            <pub-id pub-id-type="pmid">25121158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r32">
          <label>32</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Yoham</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Casadesus</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <chapter-title>Rho(D) Immune Globulin</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>22</day>
            <pub-id pub-id-type="pmid">32491807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aleman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Althabe</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Beliz&#x000e1;n</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bergel</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Bed rest during pregnancy for preventing miscarriage.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2005</year>
            <month>Apr</month>
            <day>18</day>
            <volume>2005</volume>
            <issue>2</issue>
            <fpage>CD003576</fpage>
            <pub-id pub-id-type="pmid">15846669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walsh</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Maternal activity restriction to reduce preterm birth: Time to put this fallacy to bed.</article-title>
            <source>Aust N Z J Obstet Gynaecol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>60</volume>
            <issue>5</issue>
            <fpage>813</fpage>
            <page-range>813-815</page-range>
            <pub-id pub-id-type="pmid">32691407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cargill</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Glanc</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound Evaluation of First Trimester Complications of Pregnancy.</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>38</volume>
            <issue>10</issue>
            <fpage>982</fpage>
            <page-range>982-988</page-range>
            <pub-id pub-id-type="pmid">27720100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huchon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Deffieux</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Beucher</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Capmas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Carcopino</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Costedoat-Chalumeau</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Delabaere</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gallot</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Iraola</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lavoue</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Legendre</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lejeune-Saada</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Leveque</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nedellec</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nizard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Quibel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Subtil</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vialard</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lemery</surname>
                <given-names>D</given-names>
              </name>
              <collab>Coll&#x000e8;ge National des Gyn&#x000e9;cologues Obst&#x000e9;triciens Fran&#x000e7;ais</collab>
            </person-group>
            <article-title>Pregnancy loss: French clinical practice guidelines.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>201</volume>
            <fpage>18</fpage>
            <page-range>18-26</page-range>
            <pub-id pub-id-type="pmid">27039249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mellerup</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>S&#x000f8;rensen</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Kuriigamba</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Rudnicki</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Management of abortion complications at a rural hospital in Uganda: a quality assessment by a partially completed criterion-based audit.</article-title>
            <source>BMC Womens Health</source>
            <year>2015</year>
            <month>Sep</month>
            <day>20</day>
            <volume>15</volume>
            <fpage>76</fpage>
            <pub-id pub-id-type="pmid">26388296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schindler</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Carp</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Druckmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Genazzani</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pasqualini</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schweppe</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Szekeres-Bartho</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens.</article-title>
            <source>Gynecol Endocrinol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>447</fpage>
            <page-range>447-9</page-range>
            <pub-id pub-id-type="pmid">25976550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Milman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pregnancy of unknown location.</article-title>
            <source>CMAJ</source>
            <year>2020</year>
            <month>Sep</month>
            <day>28</day>
            <volume>192</volume>
            <issue>39</issue>
            <fpage>E1132</fpage>
            <pub-id pub-id-type="pmid">32989026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r40">
          <label>40</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Redinger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <chapter-title>Incomplete Miscarriage</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">32644497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30087.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Webster</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eadon</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fishburn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>G</given-names>
              </name>
              <collab>Guideline Committee</collab>
            </person-group>
            <article-title>Ectopic pregnancy and miscarriage: diagnosis and initial management: summary of updated NICE guidance.</article-title>
            <source>BMJ</source>
            <year>2019</year>
            <month>Nov</month>
            <day>13</day>
            <volume>367</volume>
            <fpage>l6283</fpage>
            <pub-id pub-id-type="pmid">31722871</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
